000 01528 a2200421 4500
005 20250517024517.0
264 0 _c20160216
008 201602s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00340-15
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStein, Daniel S
245 0 0 _aOpen-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_c2015
300 _a3493-500 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aFemale
650 0 4 _aHealthy Volunteers
650 0 4 _aHumans
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuinolines
_xadministration & dosage
650 0 4 _aSpiro Compounds
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aJain, Jay Prakash
700 1 _aKangas, Michael
700 1 _aLefèvre, Gilbert
700 1 _aMachineni, Surendra
700 1 _aGriffin, Paul
700 1 _aLickliter, Jason
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 59
_gno. 6
_gp. 3493-500
856 4 0 _uhttps://doi.org/10.1128/AAC.00340-15
_zAvailable from publisher's website
999 _c24777609
_d24777609